Savencia - actions et droits de vote - information mensuelle Actions et droits de vote – information mensuelle Au 30 avril 2025, le capital social se composait de 14 032 930 actions représentant un nombre total de droits de vote théoriques de 23 875 132 et un nombre total de droits de vote nets de 22 790 715. Pièces jointes
Savencia - actions et droits de vote - information mensuelle Actions et droits de vote – information mensuelle Au 31 mai 2025, le capital social se composait de 14 032 930 actions représentant un nombre total de droits de vote théoriques de 23 872 484 et un nombre total de droits de vote nets de 22 786 678. Pièce jointe
Savencia - actions et droits de vote - information mensuelle Actions et droits de vote – information mensuelle Au 30 juin 2025, le capital social se composait de 14 032 930 actions représentant un nombre total de droits de vote théoriques de 23 873 484 et un nombre total de droits de vote nets de 22 786 262. Pièce jointe
Savencia - actions et droits de vote - information mensuelle Actions et droits de vote – information mensuelle Au 31 juillet 2025, le capital social se composait de 14 032 930 actions représentant un nombre total de droits de vote théoriques de 23 873 476 et un nombre total de droits de vote nets de 22 786 340. Pièce jointe
2Q'25 vs. 2Q'24 Results Sales: € 275.9 M (+10.4% vs. +10.7% BS(e) and +9.3% consensus); EBITDA: € 50.9 M (-2.1% vs. +2.9% BS(e) and +1.2% consensus); EBIT: € 11.2 M (-35.6% vs. -5.2% BS(e) and -4.6% consensus); Net Profit: € 6.3 M (-21.3% vs. -3.7% BS(e) and -10.0% consensus); 1H'25 vs. 1H'24 Results Sales: € 560.5 M (+12.7% vs. +12.9% BS(e) and +12.2% consensus); EBITDA: € 121.8 M (+16.6% vs. +19.0% BS(e) and +18.2% consensus); EBIT: € 45.4 M (+26.5% vs. +41.2% BS(e) and +41.5% consensus); Net ...
Rdos. 2T'25 vs 2T'24: Ventas: 275,9 M euros (+10,4% vs +10,7% BS(e) y +9,3% consenso); EBITDA: 50,9 M euros (-2,1% vs +2,9% BS(e) y +1,2% consenso); EBIT: 11,2 M euros (-35,6% vs -5,2% BS(e) y -4,6% consenso); BDI: 6,3 M euros (-21,3% vs -3,7% BS(e) y -10,0% consenso). Rdos. 1S'25 vs 1S'24: Ventas: 560,5 M euros (+12,7% vs +12,9% BS(e) y +12,2% consenso); EBITDA: 121,8 M euros (+16,6% vs +19,0% BS(e) y +18,2% consenso); EBIT: 45,4 M euros (+26,5% vs +41,2% BS(e) y +41,5% consenso); BDI: 28,4 M e...
NEWS SUMMARY: ALMIRALL, COLONIAL, IBERDROLA, TALGO. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 2Q’25 results to be released over the coming days in Spain. ECB keeps interest rates unchanged European stock markets saw a session that ended worse than it began, where the IBEX stood out with a gain of more than 1.5% to 14,250 points. Among the factors behind this performance w...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ALMIRALL, COLONIAL, IBERDROLA, TALGO. EUROPA: ENI, LVMH, VOLKSWAGEN. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 2T’25 que se publicarán en España y Europa en los próximos días. El BCE mantiene los tipos de interés Las bolsas europeas vivieron una sesión de más a menos, con el Ibex volviendo a sobresalir...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Almirall, S.A. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 30 June 2025 in which we reassessed the appropriateness of the ratings in the context of the...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.